Page 6 - Newslettter March 2564
P. 6
สามารถอ่านบทความเพิ่มเติมเกี่ยวกับประสิทธิภาพของวัคซีนชนิดต่างๆดังนี้
1. Hotez, P. J., Nuzhath, T., Callaghan, T., & Colwell, B. (2021). COVID-19 Vaccine
Decisions: Considering the Choices and Opportunities. Microbes and Infection,
104811. doi:https://doi.org/10.1016/j.micinf.2021.104811
2. Bhopal, S. S., Olabi, B., & Bhopal, R. (2021). Vaccines for COVID-19: learning from ten
phase II trials to inform clinical and public health vaccination programmes. Public
Health, 193, 57-60. doi:https://doi.org/10.1016/j.puhe.2021.01.011
3. Sadarangani, M., Abu Raya, B., Conway, J. M., Iyaniwura, S. A., Falcao, R. C., Colijn, C., .
. . Gantt, S. (2021). Importance of COVID-19 vaccine efficacy in older age groups.
Vaccine, 39(15), 2020-2023. doi:https://doi.org/10.1016/j.vaccine.2021.03.020
4. Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J.
(2021). What defines an efficacious COVID-19 vaccine? A review of the challenges
assessing the clinical efficacy of vaccines against SARS-CoV-2. The Lancet Infectious
Diseases, 21(2), e26-e35. doi:https://doi.org/10.1016/S1473-3099(20)30773-8
5. Deva Priya, S.A., Kavitha, S., Venugopal, P. et al. Can mRNA Vaccines Turn the Tables
During the COVID-19 Pandemic? Current Status and Challenges. Clin Drug
Investig (2021). https://doi-org.chula.idm.oclc.org/10.1007/s40261-021-01022-9